Kourtney Houser and John Hovanesian discuss how dropless therapy regimens with OMIDRIA® equal – and can potentially exceed – the current standard of care in cataract surgery regimens.
Dr. Donnenfeld sheds light on the myriad of benefits of integrating OMIDRIA in cataract surgery, encompassing a reduced postoperative drop regimen and an enhanced patient journey.
Dr. Wilson shares his study results demonstrating that OMIDRIA is safe for use in children and maintained mydrias during cataract surgery.
Dr. Visco discusses the surgical and patient benefits of continuous intracameral administration of OMIDRIA.
This retrospective study shows that patients receiving OMIDRIA and topical NSAID without postoperative topical steroids had lower rates of CME, breakthrough iritis, and pain after cataract surgery when compared with conventional perioperative topical steroids.
This retrospective study demonstrated a reduction in the quantity of opioids prescribed for patients receiving OMIDRIA during cataract surgery. The study also hypothesized that the use of OMIDRIA intraoperatively may decrease patient exposure to opioids after cataract surgery as well as the volume of pills potentially diverted into the community.
This prospective study demonstrated that patients treated with OMIDRIA had a statistically significant lower use of fentanyl intraoperatively while also experiencing significantly less pain than those treated with epinephrine.
Listen to Drs McCabe and Singh share challenges with topical post-operative cataract surgery regimens, their OMIDRIA study, and how a dropless future may be here sooner than you think
Listen to Drs Wiley and Hura discuss why they started using OMIDRIA and how implementing it has led to an improved surgical experience for patients, surgeons, and staff.
Drs Wiley and Hura share how OMIDRIA contributes to the art of refractive cataract surgery
Expanding the focus beyond the immediate intraoperative benefits of OMIDRIA
Learn why Dr. Visco uses OMIDRIA at her ASC to deliver a better experience to surgical patients.
Hear Dr. Walter share the benefits of OMIDRIA in both patient chair time and improved outcomes.
Listen to Dr. Silverstein discuss how maintaining pupil size during cataract surgery plays a key role in achieving a positive surgical experience and positive patient outcomes.
Learn about real world evidence studies that show lower rates of post-operative CME and why it makes sense to have OMIDRIA on board
See why Dr. Walter describes OMIDRIA as a great red-zone defense.
Dr. Silverstein discusses how OMIDRIA significantly reduced all 3 facets of IFIS in this real world study among male patients with a history of tamsulosin usage.
Bios: Dr. Eric Donnenfeld Dr. Eric Donnenfeld is an internationally recognized surgeon and expert in refractive, cornea and cataract surgery in the United States. He has won numerous awards, including being named Newsweek’s best ophthalmologist in America in both 2022 and 2021. He is currently a National Medical Director…
Bios: Dr Inder Paul Singh (host) Dr Inder Paul Singh president of The Eye Centres of Racine & Kenosha Ltd. in Wisconsin. His clinical research has been published and presented at various national meetings and universities around the world. Dr. Singh was also named America's Best Eye Doctor in 2021…
Bios: Dr Arjan Hura (host) Dr Arjan Hura is a cataract, refractive, and anterior segment surgeon at the Maloney-Shamie Vision Institute in Los Angeles, CA. Dr. Hura is committed to the American Academy of Ophthalmology‘s mission of protecting sight and empowering lives. His research and clinical interests include working with…
Bios: Dr Arjan Hura (host) Dr Arjan Hura is a cataract, refractive, and anterior segment surgeon at the Maloney-Shamie Vision Institute in Los Angeles, CA. Dr. Hura is committed to the American Academy of Ophthalmology‘s mission of protecting sight and empowering lives. His research and clinical interests include working with…
Bios: Dr Arjan Hura (host) Dr Arjan Hura is a cataract, refractive, and anterior segment surgeon at the Maloney-Shamie Vision Institute in Los Angeles, CA. Dr Hura is committed to the American Academy of Ophthalmology‘s mission of protecting sight and empowering lives. His research and clinical interests include working with…
Bios: Dr Arjan Hura (host) Dr Arjan Hura is a cataract, refractive, and anterior segment surgeon at the Maloney-Shamie Vision Institute in Los Angeles, CA. Dr. Hura is committed to the American Academy of Ophthalmology‘s mission of protecting sight and empowering lives. His research and clinical interests include working with…
OMIDRIA® is added to ophthalmic irrigating solution used during cataract surgery or intraocular lens replacement and is indicated for maintaining pupil size by preventing intraoperative miosis and reducing postoperative ocular pain.
OMIDRIA must be added to irrigating solution prior to intraocular use.
OMIDRIA is contraindicated in patients with a known hypersensitivity to any of its ingredients.
Systemic exposure to phenylephrine may cause elevations in blood pressure.
Use OMIDRIA with caution in individuals who have previously exhibited sensitivities to acetylsalicylic acid, phenylacetic acid derivatives, and other nonsteroidal anti-inflammatory drugs (NSAIDs), or have a past medical history of asthma.
The most commonly reported adverse reactions at ≥ 2% are eye irritation, posterior capsule opacification, increased intraocular pressure, and anterior chamber inflammation.
Please see the Full Prescribing Information for OMIDRIA.
You are encouraged to report Suspected Adverse Reactions to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
This site is intended for US Physician educational purposes only, using scientific exchange around the OMIDRIA experience.
Rayner, the Rayner logo, OMIDRIA, the OMIDRIA logo, and OMIDRIAssure are proprietary marks of Rayner. ©2023 Rayner Group, all rights reserved. US-OM-2200071v4 11/23
